Delivery Order SPE2DB22D2206-SPE2DB24FFK77
Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,264.79 order is for the supply of Lidocaine 5% Patches to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,952.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4564110488 - Lidocaine 5% Patch 30S, and has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the corporate office division of major pharmaceutical distributor Amerisourcebergen Corporation. The $1,548.67 contract is for the supply of Lidocaine 5% Patches, a topical anesthetic medication, to support the DLA's medical supply requirements. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, valued at $1,464.96, is to provide Lidocaine 5% Patches to the Defense Logistics Agency (DLA) Troop Support Medical, which supports the U.S. Department of Defense. Amerisourcebergen Drug Corporation is the prime contractor and there is no set-aside designation. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lidocaine 5% Patches. The $1,954.88 award has a completion date of May 17, 2022. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds with DLA. The IDC, which...
- The Defense Logistics Agency (DLA) awarded a $7,169.35 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Lidocaine 5% patches. This delivery order falls under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceuticals and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $40,021.94 award is for the delivery of Lidocaine 5% Patches to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,554.30 to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. This delivery order is for the supply of Lidocaine 5% Patch 30s, a specialty pharmaceutical product. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The contract, valued at $1,368.06, is for the delivery of Lidocaine 5% Patches. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, holds an indefinite delivery contract (IDC) with...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFK77Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,568.35 contract is for the delivery of Lidocaine 5% Patches in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to the Department of Defense. This specific delivery order has no set-aside designation.
Generated 5/2/24, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 2/1/24 |